468 related articles for article (PubMed ID: 16964198)
1. BioXell: an Italian biotech success story?
Sheridan C
Nat Biotechnol; 2006 Sep; 24(9):1045-6. PubMed ID: 16964198
[No Abstract] [Full Text] [Related]
2. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
3. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
4. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
5. The stampede to convertibles.
Jacobs T
Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
[No Abstract] [Full Text] [Related]
6. When your stock takes a nosedive.
Jacobs T
Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152
[No Abstract] [Full Text] [Related]
7. Public companies get creative in raising finance.
Hodgson J
Nat Biotechnol; 2010 Apr; 28(4):301-2. PubMed ID: 20379161
[No Abstract] [Full Text] [Related]
8. The 802 million dollars fallacy.
Hodgson J
Nat Biotechnol; 2004 Sep; 22(9):1076. PubMed ID: 15340464
[No Abstract] [Full Text] [Related]
9. Sustaining agbiotechnology through lean times.
McElroy D
Nat Biotechnol; 2003 Sep; 21(9):996-1002. PubMed ID: 12949560
[No Abstract] [Full Text] [Related]
10. Could bank loans solve Europe's biotech financing slump?
Mitchell P
Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
[No Abstract] [Full Text] [Related]
11. Biotech's wellspring: the health of private biotech in 2012.
Huggett B
Nat Biotechnol; 2013 May; 31(5):396-403. PubMed ID: 23657390
[No Abstract] [Full Text] [Related]
12. A reprise for collaborative financing in biotech.
Ransom J
Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110
[No Abstract] [Full Text] [Related]
13. Hedge funds gain edge by doubling biotech investments.
Ransom J
Nat Biotechnol; 2006 Apr; 24(4):373-4. PubMed ID: 16601707
[No Abstract] [Full Text] [Related]
14. Biotech financing retrenches in Q2.
Lawrence S
Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116
[No Abstract] [Full Text] [Related]
15. My worst biotech investment.
Jacobs T
Nat Biotechnol; 2006 Apr; 24(4):401. PubMed ID: 16601718
[No Abstract] [Full Text] [Related]
16. Another clue to biotech value.
Jacobs T
Nat Biotechnol; 2003 Jul; 21(7):746. PubMed ID: 12833091
[No Abstract] [Full Text] [Related]
17. Biotech venture capital--it's not too late to be early.
Klausner A
Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
[No Abstract] [Full Text] [Related]
18. Biotech holds steady in Q4.
Mitchell P
Nat Biotechnol; 2004 Feb; 22(2):135-6. PubMed ID: 14755275
[No Abstract] [Full Text] [Related]
19. US credit crunch impacts biotech across the globe.
Mitchell P
Nat Biotechnol; 2008 Apr; 26(4):359-60. PubMed ID: 18391997
[No Abstract] [Full Text] [Related]
20. Biotech IPOs: handle with care.
Jacobs T
Nat Biotechnol; 2003 Dec; 21(12):1437. PubMed ID: 14647322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
